Clear Search

Showing 1 result for “Hua X” published 2022.

October 2022

Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials

Front Pharmacol. 2022;13:935823 DOI: 10.3389/fphar.2022.935823

This meta-analysis investigated the effects of a range of doses of semaglutide in obese or overweight patients without diabetes. Other meta-analyses have investigated effects in patients with or without diabetes and assessed only the 2.4 mg-once-weekly dose of semaglutide.

more…